These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36497023)

  • 1. Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer.
    Madsen EA; Thorlacius-Ussing J; Nissen NI; Jensen C; Chen IM; Johansen JS; Diab HMH; Jørgensen LN; Hansen CP; Karsdal MA; Willumsen N
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type XX Collagen Is Elevated in Circulation of Patients with Solid Tumors.
    Thorlacius-Ussing J; Jensen C; Madsen EA; Nissen NI; Manon-Jensen T; Chen IM; Johansen JS; Diab HMH; Jørgensen LN; Karsdal MA; Willumsen N
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinoma.
    Nissen NI; Johansen AZ; Chen IM; Jensen C; Madsen EA; Hansen CP; Thorlacius-Ussing J; Karsdal M; Johansen JS; Diab HMH; Jørgensen LN; Willumsen N
    Front Mol Biosci; 2023; 10():1158058. PubMed ID: 36968276
    [No Abstract]   [Full Text] [Related]  

  • 4. Noninvasive prognostic biomarker potential of quantifying the propeptides of Type XI collagen alpha-1 chain (PRO-C11) in patients with pancreatic ductal adenocarcinoma.
    Nissen NI; Kehlet S; Johansen AZ; Chen IM; Karsdal M; Johansen JS; Diab HMH; Jørgensen LN; Sun S; Manon-Jensen T; He Y; Langholm L; Willumsen N
    Int J Cancer; 2021 Jul; 149(1):228-238. PubMed ID: 33687786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibrogenesis.
    Pedersen RS; Nissen NI; Jensen C; Thorlacius-Ussing J; Manon-Jensen T; Olesen ML; Langholm LL; Diab HMH; Jorgensen LN; Hansen CP; Chen IM; Johansen JS; Karsdal MA; Willumsen N
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer.
    Willumsen N; Ali SM; Leitzel K; Drabick JJ; Yee N; Polimera HV; Nagabhairu V; Krecko L; Ali A; Maddukuri A; Moku P; Ali A; Poulose J; Menon H; Pancholy N; Costa L; Karsdal MA; Lipton A
    Sci Rep; 2019 Dec; 9(1):19761. PubMed ID: 31875000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of type XVII collagen (BP180) ectodomain are elevated in circulation from patients with multiple cancer types and is prognostic for patients with metastatic colorectal cancer.
    Crespo-Bravo M; Thorlacius-Ussing J; Nissen NI; Pedersen RS; Boisen MK; Liljefors M; Johansen AZ; Johansen JS; Karsdal MA; Willumsen N
    BMC Cancer; 2023 Oct; 23(1):949. PubMed ID: 37803411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adenocarcinoma.
    Nissen NI; Johansen AZ; Chen I; Johansen JS; Pedersen RS; Hansen CP; Karsdal MA; Willumsen N
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types.
    Willumsen N; Jensen C; Green G; Nissen NI; Neely J; Nelson DM; Pedersen RS; Frederiksen P; Chen IM; Boisen MK; Johansen AZ; Madsen DH; Svane IM; Lipton A; Leitzel K; Ali SM; Erler JT; Hurkmans DP; Mathijssen RHJ; Aerts J; Eslam M; George J; Christiansen C; Bissel MJ; Karsdal MA
    Cell Mol Life Sci; 2022 Mar; 79(4):204. PubMed ID: 35332383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer.
    Chen IM; Willumsen N; Dehlendorff C; Johansen AZ; Jensen BV; Hansen CP; Hasselby JP; Bojesen SE; Pfeiffer P; Nielsen SE; Holländer NH; Yilmaz MK; Karsdal M; Johansen JS
    Int J Cancer; 2020 May; 146(10):2913-2922. PubMed ID: 31642523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of elevated serum soluble CD40 ligand levels as a diagnostic and prognostic tumor marker for pancreatic ductal adenocarcinoma.
    Chung HW; Lim JB
    J Transl Med; 2014 Apr; 12():102. PubMed ID: 24745825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type XII collagen is elevated in serum from patients with solid tumors: a non-invasive biomarker of activated fibroblasts.
    Crespo-Bravo M; Hettich A; Thorlacius-Ussing J; Cox TR; Karsdal MA; Willumsen N
    Clin Exp Med; 2024 Jul; 24(1):166. PubMed ID: 39048763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer.
    Christensen TD; Jensen C; Larsen O; Leerhøy B; Hansen CP; Madsen K; Høgdall D; Karsdal MA; Chen IM; Nielsen D; Johansen JS; Willumsen N
    Int J Cancer; 2023 Mar; 152(5):1036-1049. PubMed ID: 36455598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type IX Collagen Turnover Is Altered in Patients with Solid Tumors.
    Port H; He Y; Karsdal MA; Madsen EA; Bay-Jensen AC; Willumsen N; Holm Nielsen S
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa.
    Wang S; Bager CL; Karsdal MA; Chondros D; Taverna D; Willumsen N
    J Transl Med; 2021 Jan; 19(1):39. PubMed ID: 33478521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution.
    Le Calvé B; Griveau A; Vindrieux D; Maréchal R; Wiel C; Svrcek M; Gout J; Azzi L; Payen L; Cros J; de la Fouchardière C; Dubus P; Guitton J; Bartholin L; Bachet JB; Bernard D
    Oncotarget; 2016 May; 7(22):32100-12. PubMed ID: 27050073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma - A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients.
    Jensen C; Holm Nielsen S; Eslam M; Genovese F; Nielsen MJ; Vongsuvanh R; Uchila R; van der Poorten D; George J; Karsdal MA; Leeming DJ; Willumsen N
    J Hepatocell Carcinoma; 2020; 7():301-313. PubMed ID: 33204663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum fibrinogen as a diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma.
    Chung KH; Lee JC; Lee J; Cho IK; Kim J; Jang W; Yoo BC; Hwang JH
    Pancreatology; 2020 Oct; 20(7):1465-1471. PubMed ID: 32873483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI.
    Erstad DJ; Sojoodi M; Taylor MS; Jordan VC; Farrar CT; Axtell AL; Rotile NJ; Jones C; Graham-O'Regan KA; Ferreira DS; Michelakos T; Kontos F; Chawla A; Li S; Ghoshal S; Chen YI; Arora G; Humblet V; Deshpande V; Qadan M; Bardeesy N; Ferrone CR; Lanuti M; Tanabe KK; Caravan P; Fuchs BC
    Clin Cancer Res; 2020 Sep; 26(18):5007-5018. PubMed ID: 32611647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC).
    Lianyuan T; Dianrong X; Chunhui Y; Zhaolai M; Bin J
    Cancer Biol Ther; 2018 Apr; 19(4):296-305. PubMed ID: 29313457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.